2.27
0.01 (0.44%)
At close: Sep 01, 2023, 7:57 PM

Company Description

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation.

The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products.

It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation.

The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets.

Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

 logo
Country United States
IPO Date Jul 1, 2015
Industry Medical - Devices
Sector Healthcare
Employees 295
CEO Mark A. Augusti

Contact Details

Address:
600 Technology Park Drive
Billerica, Massachusetts
United States
Website https://www.conformis.com

Stock Details

Ticker Symbol CFMS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001305773
CUSIP Number 20717E101
ISIN Number US20717E1010
Employer ID 00-0000000
SIC Code 3842

Key Executives

Name Position
Mark A. Augusti Chief Executive Officer, Pres & Director
Denise E. Pedulla J.D., M.P.H. Chief Legal Officer & Corporation Sec.
Michael Fillion Chief Operating Officer
Robert S Howe Chief Financial Officer & Treasurer
Allison Baker Director of HR
Dr. Daniel Steines M.D., MS Consultant
Eric Rickenbach Senior Vice President of US Sales
Erin Henry Corporation Controller
Farzin Khaghani Vice President of U.S. Marketing
Terrance Wong Senior Vice President of Engineering & Regulatory

Latest SEC Filings

Date Type Title
Sep 15, 2023 15-12G Filing
Sep 05, 2023 25-NSE Filing
Sep 05, 2023 4 Filing
Sep 05, 2023 4 Filing
Sep 05, 2023 4 Filing
Sep 05, 2023 4 Filing
Sep 05, 2023 4 Filing
Sep 05, 2023 4 Filing
Sep 05, 2023 4 Filing
Sep 05, 2023 4 Filing